Evidence check: Pharmakogenetik Medicheck in the context of Darmgesundheit

The combination of pharmacogenetics (Medicheck) and gut health lacks strong scientific support. Pharmacogenetic tests analyze genetic variants affecting drug metabolism—they are not validated for assessing gut microbiota or digestive issues. The provided context shows that even for established interactions like warfarin and vitamin K, a microbiome test offers no direct benefit. Similarly, MTHFR variants are often marketed with weak evidence. A standalone pharmacogenetics test cannot provide actionable recommendations for gut health. Conventional diagnostics (e.g., stool analysis, endoscopy) and medical consultation should take priority. Evidence for personalized diet or supplement advice based on such genetic variants is mostly mechanistic or marketing-driven. Conclusion: pharmacogenetics and gut health are separate domains; a Medicheck offers no clinically relevant information in this context.